Get the Weekly Intelligence Brief — top committee picks every Sunday.

ACAD vs TMDX

ACADIA Pharmaceuticals Inc. vs TransMedics Group, Inc. — AI-powered side-by-side comparison
ACAD
ACADIA Pharmaceuticals Inc.
69
Buy
VS
TMDX
TransMedics Group, Inc.
60
Buy
MetricACADTMDX
AI Score 69 60
Price $29.41 $89.39
P/E Ratio 13.07× 20.22×
ROE 31.9% 40.2%
Revenue Growth YoY
Gross Margin 91.1% 58.7%
Debt / Equity 0.06× 1.68×
Dividend Yield 0.0% 0.0%
RSI (14) 78.4 76.9
Beta 0.845 1.88
Expected Upside

AI Committee View

Current Innellis committee reasoning for ACAD versus TMDX.
ACAD leads by 9 points.

ACAD scores 69/100 (Buy) versus TMDX at 60/100 (Buy).

ACAD Committee View
83% agreement
6 analysts

The primary driver is revenue growing 47.0% yoy -- genuine top-line momentum. The main limiting factor is bollinger bandwidth of 24.3% signals elevated volatility. The committee is constructive but not yet at full conviction.

Bull Case
  • P/E of 13.2 is inexpensive for the broad market — Value
  • ROE of 32.4% shows genuine earnings power backing the valuation — Value
  • Revenue growing 47.0% YoY -- genuine top-line momentum — Growth
Bear Case
  • RSI at 78 is in overbought territory — Technical
  • Weekly RSI at 80 -- overbought on the larger timeframe too — Technical
  • Bollinger bandwidth of 24.3% signals elevated volatility — Risk
TMDX Committee View
50% agreement
6 analysts

The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 25.8% yoy -- genuine top-line momentum. Risk Analyst remains cautious — bollinger bandwidth of 26.6% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • ROE of 33.0% shows genuine earnings power backing the valuation — Value
  • Revenue growing 25.8% YoY -- genuine top-line momentum — Growth
  • EPS growing 105.5% YoY — Growth
Bear Case
  • Price-to-book of 8.8x prices in significant intangible value — Value
  • RSI at 77 is in overbought territory — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ACAD Full Analysis TMDX Full Analysis